Next Article in Journal
Strong Shift to ATR-Dependent Regulation of the G2-Checkpoint after Exposure to High-LET Radiation
Next Article in Special Issue
The Role of Coronavirus RNA-Processing Enzymes in Innate Immune Evasion
Previous Article in Journal
Cutaneous Metastases from Primary Liver Cancers: The Need for Knowledge and Differential Diagnosis
Previous Article in Special Issue
Temporal Dominance of B.1.1.7 over B.1.354 SARS-CoV-2 Variant: A Hypothesis Based on Areas of Variant Co-Circulation
Review

Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review

1
Department of Preventive Medicine, Discipline Microbiology and Immunology, State University of Medicine and Pharmacy “Nicolae Testemitanu”, 2004 Chisinau, Moldova
2
Department of Respiratory Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”, 2004 Chisinau, Moldova
3
Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester Academic Health Science Centre, Manchester M23 9LT, UK
4
The North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester M23 9LT, UK
5
Department of Biomedical Sciences, University of West Attica, 12243 Athens, Greece
6
Institute of Infection & Global Health, University of Liverpool, Liverpool L69 7BE, UK
*
Authors to whom correspondence should be addressed.
These authors have contributed equally to the work.
Academic Editor: Patrick Mercié
Life 2021, 11(6), 561; https://doi.org/10.3390/life11060561
Received: 21 May 2021 / Revised: 31 May 2021 / Accepted: 10 June 2021 / Published: 14 June 2021
(This article belongs to the Special Issue Ecology, Evolution and Epidemiology of Coronaviruses)
While molecular testing with real-time polymerase chain reaction (RT-PCR) remains the gold-standard test for COVID-19 diagnosis and screening, more rapid or affordable molecular and antigen testing options have been developed. More affordable, point-of-care antigen testing, despite being less sensitive compared to molecular assays, might be preferable for wider screening initiatives. Simple laboratory, imaging and clinical parameters could facilitate prognostication and triage. This comprehensive review summarises current evidence on the diagnostic, screening and prognostic tests for COVID-19. View Full-Text
Keywords: SARS-CoV2; COVID-19; coronavirus; diagnosis; screening; prognosis; PCR; CRISP; immunoglobulin SARS-CoV2; COVID-19; coronavirus; diagnosis; screening; prognosis; PCR; CRISP; immunoglobulin
MDPI and ACS Style

Ulinici, M.; Covantev, S.; Wingfield-Digby, J.; Beloukas, A.; Mathioudakis, A.G.; Corlateanu, A. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review. Life 2021, 11, 561. https://doi.org/10.3390/life11060561

AMA Style

Ulinici M, Covantev S, Wingfield-Digby J, Beloukas A, Mathioudakis AG, Corlateanu A. Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review. Life. 2021; 11(6):561. https://doi.org/10.3390/life11060561

Chicago/Turabian Style

Ulinici, Mariana, Serghei Covantev, James Wingfield-Digby, Apostolos Beloukas, Alexander G. Mathioudakis, and Alexandru Corlateanu. 2021. "Screening, Diagnostic and Prognostic Tests for COVID-19: A Comprehensive Review" Life 11, no. 6: 561. https://doi.org/10.3390/life11060561

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop